Literature DB >> 25621099

Shared governance in building community capacity: A case study of sleep apnea.

Euny C Lee1, Ellen P Simon2, Jillian Nickerson1, Barbara Brenner1, Sandra Talavera3, Crispin Goytia4, Guedy Arniella5, Carol R Horowitz1.   

Abstract

East Harlem has the highest diabetes mortality rate in New York City, NY. Using Community Based Participatory Research principles, the East Harlem Partnership for Diabetes Prevention-a community- academic partnership-formed to build community capacity with a goal to address health disparities in East Harlem. As part of prevention efforts, community partners chose to study the prevalence of obstructive sleep apnea and its relationship to pre-diabetes and progression to diabetes. However, community partners insisted any study of sleep apnea go beyond simple assessment to ensure the largely uninsured, minority population enrolled also have access to state of the art diagnosis and treatment. Through compromise and collaboration, the partnership developed a culturally appropriate and scientifically rigorous method to diagnose and treat sleep apnea as part of a novel research program.

Entities:  

Keywords:  East Harlem; Obstructive sleep apnea; community capacity building; community-based participatory research; diabetes prevention; underserved communities

Year:  2013        PMID: 25621099      PMCID: PMC4302721     

Source DB:  PubMed          Journal:  Int Public Health J        ISSN: 1947-4989


  19 in total

1.  Results of a pilot diabetes prevention intervention in East Harlem, New York City: Project HEED.

Authors:  Punam Parikh; Ellen P Simon; Kezhen Fei; Helen Looker; Crispin Goytia; Carol R Horowitz
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

Review 2.  Obstructive sleep apnea: role in the risk and severity of diabetes.

Authors:  Sushmita Pamidi; Renee S Aronsohn; Esra Tasali
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-10       Impact factor: 4.690

3.  Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women.

Authors:  T Young; L Evans; L Finn; M Palta
Journal:  Sleep       Date:  1997-09       Impact factor: 5.849

Review 4.  Disorders of glucose metabolism in sleep apnea.

Authors:  Naresh M Punjabi; Vsevolod Y Polotsky
Journal:  J Appl Physiol (1985)       Date:  2005-11

5.  Evaluation of a single-channel portable monitor for the diagnosis of obstructive sleep apnea.

Authors:  Burcu Oktay; Thomas B Rice; Charles W Atwood; Michael Passero; Neeraj Gupta; Rachel Givelber; Oliver J Drumheller; Patricia Houck; Nancy Gordon; Patrick J Strollo
Journal:  J Clin Sleep Med       Date:  2011-08-15       Impact factor: 4.062

6.  Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).

Authors:  Elizabeth L M Barr; Paul Z Zimmet; Timothy A Welborn; Damien Jolley; Dianna J Magliano; David W Dunstan; Adrian J Cameron; Terry Dwyer; Hugh R Taylor; Andrew M Tonkin; Tien Y Wong; John McNeil; Jonathan E Shaw
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

7.  Obstructive sleep apnea as a risk factor for type 2 diabetes.

Authors:  Nader Botros; John Concato; Vahid Mohsenin; Bernardo Selim; Kervin Doctor; Henry Klar Yaggi
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

8.  Underdiagnosis of sleep apnea syndrome in U.S. communities.

Authors:  Vishesh Kapur; Kingman P Strohl; Susan Redline; Conrad Iber; George O'Connor; Javier Nieto
Journal:  Sleep Breath       Date:  2002-06       Impact factor: 2.816

9.  Global estimates of the prevalence of diabetes for 2010 and 2030.

Authors:  J E Shaw; R A Sicree; P Z Zimmet
Journal:  Diabetes Res Clin Pract       Date:  2009-11-06       Impact factor: 5.602

10.  Increased risk of lost workdays prior to the diagnosis of sleep apnea.

Authors:  Noora Sjösten; Jussi Vahtera; Paula Salo; Tuula Oksanen; Tarja Saaresranta; Marianna Virtanen; Jaana Pentti; Mika Kivimäki
Journal:  Chest       Date:  2009-03-24       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.